• Leukemias, lymphomas, and other hematologic cancers

Teniposide Generic Name & Formulations

General Description

Teniposide 10mg/mL; soln for IV infusion after dilution; contains benzyl alcohol, polyoxy 35 castor oil, dehydrated alcohol.

Pharmacological Class

Topoisomerase inhibitor.

How Supplied

Contact supplier.

Teniposide Indications


Refractory childhood acute lymphoblastic leukemia.

Teniposide Dosage and Administration

Adults and Children

See full labeling. Give as slow IV infusion (at least 30–60mins). Patients failing induction therapy with a cytarabine-containing regimen: 165mg/m2 + cytarabine twice weekly for 8 to 9 doses. Refractory to vincristine/prednisone-containing regimen: 250mg/m2 + vincristine weekly for 4 to 8 weeks + oral prednisone for 28 days.

Teniposide Contraindications

Not Applicable

Teniposide Boxed Warnings

Boxed Warning

Should be administered under the supervision of an experienced physician. Severe myelosuppression with resulting infection or bleeding may occur. Hypersensitivity reactions.

Teniposide Warnings/Precautions


Dose-limiting bone marrow suppression. Monitor for hypersensitivity reactions following infusion; have epinephrine available. Risk of hypotension with rapid IV administration. Hepatic dysfunction. Monitor and obtain CBCs with differential, hemoglobin, platelets, renal and hepatic functions before, during, and after therapy. Down syndrome (use reduced dose). Monitor children with hypoalbuminemia. Avoid extravasation. Pregnancy (Cat.D); avoid use. Nursing mothers: not recommended.

Teniposide Pharmacokinetics

See Literature

Teniposide Interactions


Potentiated by tolbutamide, sodium salicylate, and sulfamethizole. Concomitant vincristine sulfate may cause neuropathy. Concomitant antiemetics in patients given high doses of teniposide may increase risk of CNS depression, hypotension.

Teniposide Adverse Reactions

Adverse Reactions

Myelosuppression (leukopenia, neutropenia, thrombocytopenia, anemia), mucositis, GI upset, infection, alopecia, bleeding, rash, fever, hypotension, CNS depression, hypersensitivity reactions (may be fatal).

Teniposide Clinical Trials

See Literature

Teniposide Note


Formerly known under the brand name Vumon.

Teniposide Patient Counseling

See Literature